Drug Kinetics – Products
Product
Advertisement
Don't Gamble With Your Research: The Winning Hand of Label-Free Protein Characterization
Engaging in research is like participating in a high-stakes poker match. The potential reward? The discovery of the next blockbuster drug. The gamble? Risking billions on a molecule that doesn't pay off. In this game, the winning hand lies in the tools that can identify the most promising leads.
App Note / Case Study
Determine Kinetics Earlier in the Drug Discovery Process
This app note highlights how reliable kinetics and affinity for high-affinity interactions can be obtained from significantly less data than is commonly used.
Product
Advertisement
SCIEX Echo(R) MS system: Accelerating drug discovery with acoustic ejection mass spectrometry
Echo® MS system- redefining high-throughput quantification workflows. This Acoustic Ejection Mass Spectrometry (AEMS) system balances unyielding data quality, speed, and cost: adding significant value to your high-throughput screening laboratory.
Product News
Halozyme Announces Positive Clinical Data of Its High Volume Auto-Injector
Study met primary endpoint and demonstrated successful subcutaneous administration of a 10 mL biologic co-formulated with ENHANZE® in 30 seconds using Halozyme’s proprietary high-volume auto-injector.
Product News
Bio-Rad Extends Range of Anti-Idiotypic Antibodies for Use in Preclinical and Clinical Drug Development
Range of highly selective anti-idiotypic antibodies now includes six antibodies specific to dupilumab and its biosimilars for bioanalysis and Drug Monitoring.
Product News
Optibrium Releases Powerful Metabolism Prediction Capability in Next Generation StarDrop Software
Backed by six years’ research, the new StarDrop Metabolism module combines quantum mechanics and machine learning to better predict the metabolic fate of drug candidates.
Product News
TherageniX and University of Nottingham Awarded £995K Innovate UK Grant to Develop Powdered Gene Therapy for Bone Regeneration
TherageniX, have been awarded a £995,000 grant from Innovate UK. The funding will support the development of the Company’s gene therapy in a powder, a non-viral gene delivery system to improve tissue regeneration following surgery.
Product News
Avacta Announces Successful Completion of Fifth Dose Escalation in AVA6000 Phase I Clinical Study
Avacta Group plc has announced that the fifth dose escalation cohort in the ALS-6000-101 dose escalation Phase 1 clinical trial to evaluate the safety and tolerability of AVA6000 has been completed successfully.
Product News
Unique Molecule Life Cycle Platform Released: Torx® 2.0
Torx ® Software Limited, announces the release of Torx 2.0, extending the platform’s scientific reach and capabilities to deliver unrivale seamless integration across the drug discovery Design-Make-Test-Analyze (DMTA) cycle.
Product News
Revvity Launches First Scientific SaaS Platform to Accelerate Drug and Materials Development
Revvity, Inc announced the launch of its Signals Research Suite, a unified, cloud-native SaaS platform that drives scientific collaboration across R&D disciplines from drug discovery to specialty chemicals material development.
Advertisement